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67 With the development of evidence-based interventions for treatment of priority mental health conditions in 




72 To evaluate the cost-effectiveness of Problem Management Plus (PM+) intervention, compared to 




77 We randomly allocated 346 participants to either PM+ (n=172) or EUC (n=174). Effectiveness was 
78 measured using Hospital Anxiety and Depression Scale (HADS) at 3 months’ post-intervention. Cost-
79 effectiveness analysis was performed as incremental costs (measured in Pakistani Rupees [PKR] per 
80 unit change in anxiety, depression and functioning scores. 
81
82 Results 
83 The total cost of delivering PM+ per participant was estimated at PKR 16,967 (US $ 163.14) using an 
84 international master trainer and supervisor, and PKR 3,645 (US$35.04; US$ 7 per session) employing 
85 a national trainer. The mean cost per unit score improvement in anxiety and depression symptoms on 
86 HADS was PKR 2957 (95% CI: 2262, 4029) [US$ 28] with international trainer/supervision and PKR 
87 588 (95% CI: 434, 820) or US$ 6 with local trainer/supervisor. The mean Incremental Cost-
88 Effectiveness Ratio (ICER) to successfully treat a case of depression (PHQ-9 ≥ 10) using an 
89 international supervisor was PKR 53,770 (95% CI: 39,394, 77,399) [US$ 517] versus a local supervisor 
90 PKR 10,705 (95% CI: 7731, 15,627) [US$ 102.93].  
91 Conclusions
92 The PM+ was more effective but also more costly than EUC in reducing symptoms of anxiety, 
93 depression and improving functioning in adults impaired by psychological distress in a post-conflict 
94 setting of Pakistan. 
95
96 Key words: Cost-effectiveness, lay health workers, Low and Middle Income Countries (LMIC), 
97 humanitarian settings, Problem Management Plus, Common Mental Disorders (CMDs) 











103 Mental health problems cause  a significant burden of disease in Low and Middle Income Countries 
104 (LMICs), yet the documented ‘mental health treatment gap’ is up to 90% [1-3]. The need for mental 
105 health services is much greater in populations affected by humanitarian crises. More than 135 million 
106 people are in need of humanitarian assistance due to ongoing humanitarian crises and conflicts globally 
107 [4]. A systematic review and meta-analysis of mental health outcomes in population affected by conflict 
108 and displacements showed that mood and anxiety disorders were common, with rates of 17.3% for 
109 depression and 15.4% for posttraumatic stress disorder [5]. Epidemiological studies from areas affected 
110 by humanitarian crises in Pakistan found high rates of psychological distress in these populations. One 
111 study reported  rates as high as 38% to 65% for  psychological distress in women [6, 7]. Majority of 
112 people  have no access to mental health services in such settings [6]. Over the past decade, significant 
113 progress has been made in terms of availability of evidence based mental health intervention packages 
114 for populations affected by humanitarian crises [8]. However, sustainability and scalability of such 
115 psychological interventions  remains a challenge in populations affected by humanitarian crises in low 
116 resource settings globally [9].
117 We developed and tested a brief, multicomponent behavioural intervention, Problem Management Plus 
118 (PM+) delivered by lay health workers for Common Mental Disorders (CMDs) in conflict affected 
119 settings. The intervention was effective for treating the symptoms of CMDs in a post-conflict setting 
120 of Pakistan. Trial protocol and results of pilot and definitive clinical trials have been published [10-12]. 
121 In the present study, we conduct an economic evaluation alongside the randomized controlled trial to 
122 assess the cost-effectiveness of this intervention in order to inform policy and implementation in routine 
123 clinical practice.  
124 Method
125 Study site and participants 
126 Participants included 346 primary care attendees with high level of  psychological distress (score above 
127 2 on General Health Questionnaire [GHQ-12]) [13] and functional impairment (score above 16 on 
128 World Health Organization Disability Assessment Schedule 2.0 [WHODAS 2.0]) [14]. The participants 
129 were individually randomized in 1:1 ratio to either intervention arm i.e. PM+ (n=172) along with 
130 Enhanced Usual Care (EUC)) or the Control arm consisting of Enhanced Usual Care (EUC) only 
131 (n=174). The study was approved locally by the Institutional Review and Ethics Board of the 






132 Postgraduate Medical Institute, Lady Reading Hospital, Peshawar, and by the WHO Ethical Review 
133 Committee. Written informed consent was obtained from all study participants. 
134 The Intervention 
135 Participants in the intervention arm received a brief multicomponent intervention called Problem 
136 Management Plus (PM+) [15]. The  intervention is trans-diagnostic as it applies the same underlying 
137 principles across mental disorders, without tailoring the protocol to specific diagnoses [16]. PM+ is 
138 based on well-established principles of problem solving and behavioural techniques. It is designed to 
139 be used for adults experiencing common mental health problems (e.g. anxiety, stress, depression and 
140 grief) only. It is not suitable for the treatment of severe mental health problems (including psychosis or 
141 risk for suicide). Both an individual and group version of the intervention exists. The current study 
142 involves the individual version. 
143 PM+ consists of 5 weekly face-to-face sessions of 90 minutes each, delivered by trained lay health 
144 workers. The intervention is composed of four core strategies i.e. stress management, managing 
145 problems, get going, keep doing (behavioural activation), strengthening social support, introduced 
146 sequentially in the intervention sessions. In the last session, all the strategies are reviewed with a 
147 particular emphasis on using these strategies for self-management in the future and to prevent relapse. 
148
149 Training and supervision followed a cascade model. An international master trainer trained local 
150 trainers in a 6-day training workshop. Training consisted of intervention delivery, training and 
151 supervision skills. Local trainers cascaded the training to lay health workers (with 12-16 year of 
152 education) in an 8-day training. Lay health workers were provided weekly supervision by local 
153 trainers/supervisors (hereafter local supervisor) who were in turn, supervised monthly by the 
154 international master trainer/supervisor (hereafter international supervisor) via video conference for 2 
155 to 3 hours. The intervention is available in Urdu and English on the WHO website [17]. Further details 
156 of intervention are described elsewhere [15].  
157 Enhanced care as usual
158 The participants in both intervention arm and control arm received Enhanced Usual Care (EUC). The 
159 treatment was enhanced as the Primary Health Care (PHC) physicians in the participating primary 
160 health care centres received a 5-day training in the management of Common Mental Disorders (CMDs) 






161 in primary health care settings. The training was reinforced through a one-day refresher training for the 
162 primary health care physicians. The study participants in both arms were able to seek other health care 
163 services from their PHC physicians.  
164 Data Collection
165 A. Health outcomes
166 The outcomes were measured at baseline and 3 months’ post-intervention. The cost-effectiveness 
167 analysis was performed as incremental costs per unit change in anxiety, depression and functioning 
168 scores.  The primary outcome was change in symptoms of anxiety and depression measured with the 
169 Hospital Anxiety and Depression Scale (HADS) [18, 19]. Severity of symptoms was measured using 
170 the -HADS-Anxiety (anxiety; 7 items; possible score range, 0-21) and Depression (depression; 7 items; 
171 possible score range, 0-21). Higher scores indicate more anxiety and/or depression. Secondary 
172 outcomes were functional impairment and presence of depressive disorders. WHODAS-12 was used 
173 to assess functional impairment. Polytomous scoring algorithm of WHODAS-12 was used to transform 
174 the functional impairment scores on a scale of 1-100[14]. Presence of depressive disorder was measured 
175 using a 9-item Patient Health Questionnaire (PHQ-9) [20]. Other secondary outcome measure included 
176 PCL-5 [21], results of which are attached as a web appendix. 
177
178 B. Health resource use profiling 
179 The data on health resource use was collected  using  the Client Services Receipt Inventory (CSRI) 
180 [22], which records the clients’ contact with out-patient services (i.e. mental health specialist, general 
181 physician, traditional healer, community health workers etc.), inpatient (hospital admissions) services 
182 and out of pocket costs associated with travel, medications and tests/investigations during the preceding 
183 recall period. A section on seeking religious help and retreats was added to adapt the tool for use in 
184 local population.  Study participants self-reported their health-care utilization, medication use and out-
185 of-pocket expenditures on CSRI [22] at baseline and 3-months’ post-intervention. 
186
187 C. Cost measurement and analysis
188 Economic analysis was conducted primarily from a health system perspective, consisting of a) costs 
189 incurred over the trial period in the delivery of the intervention itself, b) use of other healthcare and 






190 related services by study participants, including religious help and retreats, and c) patient and family 
191 costs (such as number of days with reduced working hours, informal caregiving time by relatives or 
192 friends as well as travel costs and time spent travelling to or waiting for consultations). No discounting 
193 of costs was applied since the study was performed within one year.
194
195 Intervention costs: These included costs for the intervention adaptation workshops, translations of 
196 intervention manual and training materials; printing of adapted training manuals, staff recruitment, 
197 training and supervision. Supervision costs included time spent by master trainer, supervisors, transport 
198 costs for fieldwork supervision, and costs of all other resources used.  
199
200 To estimate the cost of intervention delivery, we evaluated unit cost per minute of health care providers’ 
201 time including the international master trainer/supervisor, local supervisors, lay health workers and 
202 physicians. The unit cost per minute was multiplied with the total estimated time spent by each health 
203 care provider to the participants to calculate the total cost of intervention delivery. We calculated the 
204 cost of intervention delivery with the international master trainer/supervisor and modelled the cost for 
205 a local supervisor as a potentially more sustainable way to support task-shifting in low resource settings. 
206 Costs of the intervention were calculated by multiplying the total contact time (number of minutes) a 
207 participant had in the intervention arm with a lay health worker by the per-minute cost of the lay health 
208 workers’ time and the costs spent on travelling by lay health workers (unit cost calculations are 
209 provided as web appendix). 
210
211 Calculation of these intervention costs as well as contacts with a range of formal health care providers 
212 was facilitated by the use of a simplified costing template for unit cost calculations reported in health 
213 economic evaluation of mental health services [23]. Unit cost templates accounted for the costs of 
214 salaries of staff employed in the provision of intervention delivery (including master trainer, 
215 supervisors, lay health workers and PHC staff), facility operating costs where the service was provided, 
216 overhead costs relating to the provision of service (personnel, finance etc.) and the capital costs of the 
217 facility where the intervention was provided (land, buildings etc.). Sources of data for these variables 
218 included public health system financial records and project’s financial records. All costs were cal-
219 culated in Pakistani rupees (PKR) and are reported in Pakistani Rupees and United States Dollars for 






220 the year 2016, when the study was implemented (1Exchange rate 1 USD= PKR 104). No adjustment 
221 was made for Purchasing Power Parity (PPP) since the focus of interest was on the actual resource costs 
222 incurred in the study country (rather than a comparison to other countries, whereby differences in the 
223 relative price of goods and services would need to be taken into account). 
224
225 Statistical Analysis 
226 The mean and standard deviation for the total cost was calculated using generalized linear regression 
227 model with Gamma distribution after adjustment for baseline total cost. The group difference and its 
228 95% CI was also calculated [24]. The Incremental Cost-effectiveness Ratio (ICER) was calculated as 
229 the additional costs of the intervention divided by the change in HADS-A, HADS- D, HADS Total, 
230 PHQ, and WHODAS related to the intervention. The confidence intervals for ICER was estimated by 
231 non-parametric bootstrapping. The bootstrap technique sampled with replacement from the original 
232 observed paired of costs and effects, maintaining the correlation structure between costs and benefits, 
233 to create a new dataset with 1000 observations. For each bootstrap resample, an estimate of differential 
234 total mean costs, expected mean effectiveness was calculated [25]. The 95% CIs for the differential 
235 estimates were derived from the calculated 2.5th and 97.5th percentiles. We plotted cost-effectiveness 
236 acceptability curves [26] to evaluate  the probability of PM+ intervention being cost-effective at 
237 increasing monetary values representing willingness-to-pay thresholds for PM+ intervention from 
238 policy makers’ perspective [27]. For the effectiveness data, we used linear mixed models to study 
239 treatment effects as indicated in our main trial report [12] which allowed the number of observations 
240 to vary at random between subjects and effectively handles missing data [28].. 14% cost data was 
241 missing for medicines, complementary medicines, seeking retreats and religious help and for outpatient 
242 services at the end point. Summary stats for each specific cost were presented without imputation but 
243 the total cost were calculated assuming missing data as 0 in a conservative way [25]. 
244
245 Results 
246 As reported in the clinical effectiveness evaluation [12], mean combined depression and anxiety 
247 symptom scores on HADS were significantly lower at 3-months post-intervention (AMD, −5.75; 95% 
1 Global Economic Data, Indicators, Charts, & Forecasts: CEIC
https://www.ceicdata.com/en






248 CI, −7.21 to −4.29). Similarly, functional impairment significantly improved (AMD, −4.17; 95% CI, 
249 −5.84 to −2.51) on WHODAS-12 in the intervention arm compared to EUC arm. At baseline depression 
250 rate was 94.2% and 89.4% in intervention and EUC arms respectively. at the end of 3-months follow 
251 up period, the intervention arm had significantly lower rates of depression (26.9%) compared to EUC 




256 No significant difference in the cost of other health-care services accessed by study participants was 
257 observed between treatment and control groups, with the exception of religious help and retreats. The 
258 mental health condition of the majority of trial participants did not result in reduction in their or their 
259 family members or friends’ usual work/activities (Table 1).  Table 2 presents summary statistics and 
260 cost results from the mixed-model analysis.  
261
262 With an international master trainer/supervisor total cost of delivering PM+ intervention per participant 
263 was PKR 16,967 (US $ 163.14). Total intervention arm costs (PM+ costs plus cost of services accessed 
264 by intervention arm) was PKR17,473 (SD, 912) or US$ 168.  The cost of EUC (treatment as usual plus 
265 cost of services accessed by control arm participant) was PKR 848 (SD, 1734) or US $ 8.15 (See Table 
266 2).  
267 Substituting the cost of international master trainer/supervisor with national trainer would substantially 
268 decrease intervention costs. Total cost of delivering PM+ intervention, involving a national master 
269 trainer/supervisor, was estimated to be PKR 3,645 (US $ 35.04). This would be PKR 729 (US $ 7.00) 
270 per session. Total costs of delivering the intervention (with a national trainer/supervisor) plus EUC in 
271 the intervention arm would be PKR  4151 (SD, 912) or US$ 40.
272
273 Cost-effectiveness 
274 Incremental cost-effectiveness ratios (ICERs) indicate that the intervention was both more effective 
275 and costlier than EUC for all the health outcomes studied (Table 3). Analysis was conducted to evaluate 
276 the cost-effectiveness of PM+ intervention under two scenarios; 1) PM+ delivery by lay health workers 






277 supervised by international master trainer/supervisor (as observed in the trial) and 2) PM+ delivery by 
278 lay health workers supervised by local supervisor. The second scenario will be the case for scale-up of 
279 the intervention package in real world setting.  The additional costs associated with the intervention led 
280 to a relative improvement in outcomes, e.g. the mean cost per unit score improvement in anxiety and 
281 depression on HADS was PKR 2957 (95% CI: 2262, 4029) or US$ 28 with an international 
282 trainer/supervisor. This would be PKR 588 (95% CI: 434, 820) or US$ 6 with a national 
283 trainer/supervisor; with an international supervisor, each 1-point improvement on WHODAS costed 
284 PKR 4097 (95% CI: 2978, 6046) or US$ 40 and with a national supervisor it was estimated to be PKR 
285 815 (95% CI: 576, 1225) or US$ 8. We plotted 1,000 resampled estimates of costs and outcomes on a 
286 cost-effectiveness plane for the primary and secondary outcomes. The results show that all the 
287 resampled estimates fall in the upper-right quadrant, i.e. PM+ intervention is ‘more effective but 
288 costlier’ in all of the resampled estimates. 
289 The mean ICER to successfully treat a case of depression (PHQ-9 cut-off 10 or above) using an 
290 international supervisor was PKR 53,770 (95% CI: 39,394, 77,399) [US$ 517] versus a local supervisor 
291 PKR 10,705 (95% CI: 7731, 15,627) [US$ 102.93].  ICERs for other outcome measures are compared 
292 in Table 3. 
293 The cost-effectiveness acceptability curves of PM+ intervention on the outcomes of HADS (anxiety & 
294 depression) and WHODAS-12 with an international specialist supervisor are provided in Figures 1a 
295 and 2a. The intervention has more than 90% probability of being cost-effective as compared to EUC 
296 above a willingness-to-pay threshold of PKR 7000 (US$ 67) for a one-point improvement in depression 
297 and anxiety (HADS Total) (Figure 1a) and PKR 6000 (US$ 57) for a one-point improvement in 
298 functioning (WHODAS) using international supervisors (Figure 2a). These thresholds would be 
299 reduced by 80% using local supervisors (Figure 1b & 2b). 
300 Discussion 
301 Our results show that PM+ intervention is more effective and more costly than EUC in reducing 
302 symptoms of anxiety and depression. Although there is inevitable uncertainty around point estimates, 
303 our analysis has shown that even at very modest levels of willingness to pay for a one-point 
304 improvement in symptoms or functioning outcomes there is at least a 90% probability of this 






305 intervention being a cost-effective use of resources compared to enhanced usual care. We concluded 
306 that the value is ‘modest’ because that amount is equivalent to, for example, less than 10% of the 
307 minimum monthly wage in Pakistan in 2017 [29]. These findings are consistent with evidence from 
308 LMICs on the cost-effectiveness of task-shifting approach to deliver psychological interventions 
309 compared with EUC delivered by primary health care physicians, for the treatment of common mental 
310 disorders [30, 31]. With the current model of training and supervision from international master 
311 trainer/supervisor, the intervention was 5 times more costly for treating one person with depression, 
312 compared to modelled costs of training and supervision from local trainers. This emphasizes the need 
313 for building the capacity for local mental health workforce [32].
314 The resources, capacity and infrastructure for mental health services research including health 
315 economic evaluation alongside randomized controlled trials is limited in humanitarian settings of 
316 LMICs [33]. This is one of the very few studies to evaluate the cost-effectiveness of a psychological 
317 intervention in a humanitarian setting. There are only a few published studies on the cost-effectiveness 
318 of task-shifting interventions in global mental health. Araya et al (2006) evaluated the incremental cost-
319 effectiveness of a stepped-care multicomponent program for the treatment of depressed women in 
320 primary care in Chile. The stepped-care program was more effective and costlier than usual care (an 
321 extra US$ 0.75 per depression-free day) [34].  Buttorff et al (2012) conducted an economic evaluation 
322 of a task-shifting intervention for the treatment of depressive and anxiety disorders in primary-care 
323 settings in India. They concluded that the use of lay heath workers for treatment of CMDs in the public 
324 primary-care facilities was not only cost-effective but also cost-saving. The mean health system cost 
325 per case recovered at the end of follow-up was US$ 128 (95% CI: 105 to 157) in the intervention arm 
326 and US$ 149 (95% CI: 131 to 169) in the control arm [30]. Other similar studies of lay-health counsellor 
327 delivered psychological interventions from India [31] have replicated the findings of cost-effectiveness 
328 of task-shifting interventions for treating depression and alcohol problems in primary care settings.   
329 Sikandar et al., (2019) evaluated the cost-effectiveness of a peer-volunteer delivered CBT based 
330 intervention for post-natal depression versus EUC in community settings of rural Pakistan. The 
331 intervention was costlier as compared to EUC but was effective in improving the severity of post-natal 
332 depression (costs per unit improvement in PHQ-9 score of US $15·50 (9·59 to 21·61) for the whole 
333 study period. The intervention had a 98% probability of being cost-effective over a willingness-to-pay 






334 threshold of US$ 60 per unit of improvement on PHQ-9 score  compared to EUC [35]. Although it is 
335 difficult to compare the results of cost-effectiveness evaluations across studies due to differences in 
336 analytical approaches, treatment conditions and different outcome measures, the results of these studies 
337 demonstrate cost-effectiveness of brief psychological intervention using a task-shifting approach.  
338 During humanitarian crises, health systems tend to be overwhelmed, human resources are overstretched 
339 and access to specialists for referral and support is limited. It is therefore, important to determine how 
340 interventions with proven efficacy can be scaled-up in a cost effective way [36]. Our study and evidence 
341 from the literature supports the effectiveness of implementation strategies such as task-shifting and 
342 trans-diagnostic approaches to bridge the treatment gap for mental health problems in low resource 
343 settings. With the increased availability of evidence-based psychological intervention packages, further 
344 health economic evaluations are needed to inform the resource needs to scale-up evidence-based care 
345 for mental health. 
346 Limitations 
347 A limitation of the cost-effectiveness approach used in our study is that the results are limited to direct 
348 health care costs and health-related outcomes of PM+ intervention, and does not extend to the wider 
349 economic or social value of investing in mental health, which may be quite significant in a humanitarian 
350 context.  The future health economic evaluations in global mental health will benefit by integrating the 
351 opportunity and time cost of lay health workers and non-specialists. The added value that results from 
352 such task-sharing implementation strategies in terms of empowerment, opportunities and career growth 
353 for non-specialist health work force as well as increase in treatment coverage for priority mental health 
354 conditions will also need to be accounted for in future studies.  We did not make any adjustment for 
355 purchasing power parity since the focus of this study was on the actual resource costs incurred in the 
356 study country. However, for the purpose of international comparison, the PPP adjusted total 
357 intervention costs of PM+ were I$ 546 per participant. Estimated costs of delivering PM+ using a 
358 national master trainer in Pakistan would be I$ 114 per participant. Another limitation of our study is 
359 that we estimated costs per point reduction in symptoms of anxiety and depression and cost per case 
360 recovered from depression which limits the ability to compare results with other interventional studies 
361 on the basis of cost-utility measures (QALYs).  Future studies may use change in health outcomes that 
362 are easily interpretable and meaningful enough for policy makers to make decision and should also 






363 collect data on population-based health state preference scores that would enable the calculation of 
364 Quality Adjusted Life Years (QALYs). 
365 Conclusions
366 The literature on cost effectiveness of interventions for treating common mental disorders in LMICs, 
367 especially in humanitarian context is limited to only few studies. Present study provides the evidence 
368 on cost-effectiveness of a task-shifting intervention using a trans-diagnostic approach. We found that 
369 the intervention was effective but more costly for treating one person with depression when training 
370 and supervision to lay health workers was provided by an international master trainer. We conclude 
371 that PM+ may be a cost-effective intervention by using the training and supervision provided by the 
372 local health workers in primary health care settings. With the increased availability of evidence-based 
373 psychological intervention packages, further health economic evaluations are needed to inform the 










Table 1: *Health services utilization (including religious help and retreats, inpatient services and reduced 
usual work/activities due to health condition) across two arms at baseline and during past 3-months 
Baseline Endpoint











































professional TAU 76 
(24.5)





























































---Religious help and retreats
TAU 45 
(13.4)



















work/activities due to health 
condition (oneself/family 











member) TAU 1 (0.3) -- --- 1 
(0.3)
--- ---
 * Night stays in hospital- In case of inpatient services only
** Mean number of days of reduced usual work/activities due to health condition (oneself/family 
member)






Table 2:  Cost of health services (outpatient, inpatient care, drugs and complimentary medicines 
and religious retreats) by trial arm in PKR (1 USD = 104 PKR; 2016)
Descriptive statistics
n; mean* (SD)*
Intervention (N=172) EUC (N=174)Cost of Services Time point
N Mean  (SD) N Mean (SD)
Difference in LS 
mean (95%CI)
p-value
Out-patient care Pre-Treatment 106 2641 (14946) 95 727 (1161)
Follow-Up 73 485 (651) 72 667 (1033)  -182 (-465,101) 0.206
Change since 
baseline 
49 743(2751) 41 305(984) 437(-462,1281) 0.336
In-patient care Pre-Treatment 170 135 (929) 172 273 (1545)
Follow-Up 142 49 (344) 155 171 (1056) -122 (-304,61) 0.191
Change since 
baseline
140 114(866) 153 108(1953) 6(-337,349) 0.971
Drugs/medications Pre-Treatment 158 736 (1364) 159 725 (1232)
Follow-Up 132 277 (650) 149 228 (461) 50 (-82,181) 0.458
Change since 
baseline
124 378(1314) 136 496(1341) -118(-442,207) 0.477
Complimentary 
medicines 
Pre-Treatment 168 124 (624) 167 110 (945)
Follow-Up 139 10 (88.14) 156 3 (40) 7 (-9,22) 0.393
Change since 
baseline
136 55(456) 150 115(998) -60(-244,123) 0.518
Religious Retreats Pre-Treatment 167 390 (2208) 165 674 (3773)
Follow-Up 136 4 (43) 154 131 (655) -127 (-238,-17) 0.024
Change since 
baseline
131 432(2451) 145 626(4080) -193(-983,596) 0.638
Total cost of all 
services 
Pre-Treatment 172 3145 (14302) 174 2445 (6053)
Follow-Up 145  601 (694) 159 848 (1734) -247 (-568,73) 0.130
Change since 
baseline
145 2746 (15491) 159 1714 (6632) 1032(-1709,3774) 0.444





172 17473 (912) 159 848 (1734) 16625 
(16329,16922)
<.0001




172 4151 (912) 159 848 (1734) 3303 (3007,3600) <.0001
Table 2 shows costs of other services accessed by the participants. The data was collected using CSRI at baseline 
and 3 months’ post-intervention follow-up assessment. 
2 Intervention costs plus cost of services. The cost of intervention with international supervisor is PKR 16,967
3 Intervention costs plus cost of services. The cost of intervention with local supervisor is PKR 3,645






Table 3:  Incremental Cost Effectiveness Ratios (ICERs) for PM+ intervention in PKR (1 USD = 
104 PKR; 2016)
International specialist  supervisor Local specialist supervisor 
Endpoint Mean ICER 95% CI Mean ICER 95% CI
HADS Anxiety 6172.99 [4575.49,8787.73] 1228.91 [882.86,1796.12]
HADS Depression 5704.27 [4384.51, 7651.85] 1135.81 [849.23,1561.68]
HADS Total 2957.45 [2261.64, 4029.00] 588.82 [434.01,820.27]
WHO DAS 4096.51 [2978.13, 6045.66] 815.89 [575.80,1225.10]
Depression caseness 53769.91 [39393.57, 77398.62] 10705.35 [7730.95,15627]
Note: (1) The cost was estimated after adjusting several baseline variables (baseline total cost, age, gender, occupation, marital 
status). (2) We used non-parametric bootstrapping to estimate confidence intervals with1000 resamples.
Abbreviations.; HADS = Hospital Anxiety and Depression Scales (subscale score range: 0-21; higher scores indicate elevated 
anxiety or depression, respectively); WHODAS = WHO Disability Assessment Schedule (total score range: 0-48; higher scores 
indicate more severe impairment); Depression caseness defined as (PHQ-9 cut-off 10 or above), PHQ = Patient Health 
Questionnaire 






Figure 1a: Cost-effectiveness acceptability curve for PM+ with international supervisor (in PKR) (1 USD 
= 104 PKR; 2016)






Figure 1b: Cost-effectiveness acceptability curve for PM+ - with local trainer (in PKR) (1 USD = 104 
PKR; 2016)






Figure 2a: Cost-effectiveness acceptability curve for PM+ with international supervisor (in PKR) 
(1 USD = 104 PKR; 2016)






Figure 2b: Cost-effectiveness acceptability curve for PM+ with local supervisor (in PKR) (1 USD 
= 104 PKR; 2016)
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67 With the development of evidence-based interventions for treatment of priority mental health conditions in 




72 To evaluate the cost-effectiveness of Problem Management Plus (PM+) intervention, compared to 




77 We randomly allocated 346 participants to either PM+ (n=172) or EUC (n=174). Effectiveness was 
78 measured using Hospital Anxiety and Depression Scale (HADS) at 3 months’ post-intervention. Cost-
79 effectiveness analysis was performed as incremental costs (measured in Pakistani Rupees [PKR] per 
80 unit change in anxiety, depression and functioning scores. 
81
82 Results 
83 The total cost of delivering PM+ per participant was estimated at PKR 16,967 (US $ 163.14) using an 
84 international master trainer and supervisor, and PKR 3,645 (US$35.04; US$ 7 per session) employing 
85 a national trainer. The mean cost per unit score improvement in anxiety and depression symptoms on 
86 HADS was PKR 2957 (95% CI: 2262, 4029) [US$ 28] with international trainer/supervision and PKR 
87 588 (95% CI: 434, 820) or US$ 6 with local trainer/supervisor. The mean Incremental Cost-
88 Effectiveness Ratio (ICER) to successfully treat a case of depression (PHQ-9 ≥ 10) using an 
89 international supervisor was PKR 53,770 (95% CI: 39,394, 77,399) [US$ 517] versus a local supervisor 
90 PKR 10,705 (95% CI: 7731, 15,627) [US$ 102.93].  
91 Conclusions
92 The PM+ was more effective but also more costly than EUC in reducing symptoms of anxiety, 
93 depression and improving functioning in adults impaired by psychological distress in a post-conflict 
94 setting of Pakistan. 
95
96 Key words: Cost-effectiveness, lay health workers, Low and Middle Income Countries (LMIC), 
97 humanitarian settings, Problem Management Plus, Common Mental Disorders (CMDs) 











103 Mental health problems cause  a significant burden of disease in Low and Middle Income Countries 
104 (LMICs), yet the documented ‘mental health treatment gap’ is up to 90% [1-3]. The need for mental 
105 health services is much greater in populations affected by humanitarian crises. More than 135 million 
106 people are in need of humanitarian assistance due to ongoing humanitarian crises and conflicts globally 
107 [4]. A systematic review and meta-analysis of mental health outcomes in population affected by conflict 
108 and displacements showed that mood and anxiety disorders were common, with rates of 17.3% for 
109 depression and 15.4% for posttraumatic stress disorder [5]. Epidemiological studies from areas affected 
110 by humanitarian crises in Pakistan found high rates of psychological distress in these populations. One 
111 study reported  rates as high as 38% to 65% for  psychological distress in women [6, 7]. Majority of 
112 people  have no access to mental health services in such settings [6]. Over the past decade, significant 
113 progress has been made in terms of availability of evidence based mental health intervention packages 
114 for populations affected by humanitarian crises [8]. However, sustainability and scalability of such 
115 psychological interventions  remains a challenge in populations affected by humanitarian crises in low 
116 resource settings globally [9].
117 We developed and tested a brief, multicomponent behavioural intervention, Problem Management Plus 
118 (PM+) delivered by lay health workers for Common Mental Disorders (CMDs) in conflict affected 
119 settings. The intervention was effective for treating the symptoms of CMDs in a post-conflict setting 
120 of Pakistan. Trial protocol and results of pilot and definitive clinical trials have been published [10-12]. 
121 In the present study, we conduct an economic evaluation alongside the randomized controlled trial to 
122 assess the cost-effectiveness of this intervention in order to inform policy and implementation in routine 
123 clinical practice.  
124 Method
125 Study site and participants 
126 Participants included 346 primary care attendees with high level of  psychological distress (score above 
127 2 on General Health Questionnaire [GHQ-12]) [13] and functional impairment (score above 16 on 
128 World Health Organization Disability Assessment Schedule 2.0 [WHODAS 2.0]) [14]. The participants 
129 were individually randomized in 1:1 ratio to either intervention arm i.e. PM+ (n=172) along with 
130 Enhanced Usual Care (EUC)) or the Control arm consisting of Enhanced Usual Care (EUC) only 
131 (n=174). The study was approved locally by the Institutional Review and Ethics Board of the 






132 Postgraduate Medical Institute, Lady Reading Hospital, Peshawar, and by the WHO Ethical Review 
133 Committee. Written informed consent was obtained from all study participants. 
134 The Intervention 
135 Participants in the intervention arm received a brief multicomponent intervention called Problem 
136 Management Plus (PM+) [15]. The  intervention is trans-diagnostic as it applies the same underlying 
137 principles across mental disorders, without tailoring the protocol to specific diagnoses [16]. PM+ is 
138 based on well-established principles of problem solving and behavioural techniques. It is designed to 
139 be used for adults experiencing common mental health problems (e.g. anxiety, stress, depression and 
140 grief) only. It is not suitable for the treatment of severe mental health problems (including psychosis or 
141 risk for suicide). Both an individual and group version of the intervention exists. The current study 
142 involves the individual version. 
143 PM+ consists of 5 weekly face-to-face sessions of 90 minutes each, delivered by trained lay health 
144 workers. The intervention is composed of four core strategies i.e. stress management, managing 
145 problems, get going, keep doing (behavioural activation), strengthening social support, introduced 
146 sequentially in the intervention sessions. In the last session, all the strategies are reviewed with a 
147 particular emphasis on using these strategies for self-management in the future and to prevent relapse. 
148
149 Training and supervision followed a cascade model. An international master trainer trained local 
150 trainers in a 6-day training workshop. Training consisted of intervention delivery, training and 
151 supervision skills. Local trainers cascaded the training to lay health workers (with 12-16 year of 
152 education) in an 8-day training. Lay health workers were provided weekly supervision by local 
153 trainers/supervisors (hereafter local supervisor) who were in turn, supervised monthly by the 
154 international master trainer/supervisor (hereafter international supervisor) via video conference for 2 
155 to 3 hours. The intervention is available in Urdu and English on the WHO website [17]. Further details 
156 of intervention are described elsewhere [15].  
157 Enhanced care as usual
158 The participants in both intervention arm and control arm received Enhanced Usual Care (EUC). The 
159 treatment was enhanced as the Primary Health Care (PHC) physicians in the participating primary 
160 health care centres received a 5-day training in the management of Common Mental Disorders (CMDs) 






161 in primary health care settings. The training was reinforced through a one-day refresher training for the 
162 primary health care physicians. The study participants in both arms were able to seek other health care 
163 services from their PHC physicians.  
164 Data Collection
165 A. Health outcomes
166 The outcomes were measured at baseline and 3 months’ post-intervention. The cost-effectiveness 
167 analysis was performed as incremental costs per unit change in anxiety, depression and functioning 
168 scores.  The primary outcome was change in symptoms of anxiety and depression measured with the 
169 Hospital Anxiety and Depression Scale (HADS) [18, 19]. Severity of symptoms was measured using 
170 the -HADS-Anxiety (anxiety; 7 items; possible score range, 0-21) and Depression (depression; 7 items; 
171 possible score range, 0-21). Higher scores indicate more anxiety and/or depression. Secondary 
172 outcomes were functional impairment and presence of depressive disorders. WHODAS-12 was used 
173 to assess functional impairment. Polytomous scoring algorithm of WHODAS-12 was used to transform 
174 the functional impairment scores on a scale of 1-100[14]. Presence of depressive disorder was measured 
175 using a 9-item Patient Health Questionnaire (PHQ-9) [20]. Other secondary outcome measure included 
176 PCL-5 [21], results of which are attached as a web appendix. 
177
178 B. Health resource use profiling 
179 The data on health resource use was collected  using  the Client Services Receipt Inventory (CSRI) 
180 [22], which records the clients’ contact with out-patient services (i.e. mental health specialist, general 
181 physician, traditional healer, community health workers etc.), inpatient (hospital admissions) services 
182 and out of pocket costs associated with travel, medications and tests/investigations during the preceding 
183 recall period. A section on seeking religious help and retreats was added to adapt the tool for use in 
184 local population.  Study participants self-reported their health-care utilization, medication use and out-
185 of-pocket expenditures on CSRI [22] at baseline and 3-months’ post-intervention. 
186
187 C. Cost measurement and analysis
188 Economic analysis was conducted primarily from a health system perspective, consisting of a) costs 
189 incurred over the trial period in the delivery of the intervention itself, b) use of other healthcare and 






190 related services by study participants, including religious help and retreats, and c) patient and family 
191 costs (such as number of days with reduced working hours, informal caregiving time by relatives or 
192 friends as well as travel costs and time spent travelling to or waiting for consultations). No discounting 
193 of costs was applied since the study was performed within one year.
194
195 Intervention costs: These included costs for the intervention adaptation workshops, translations of 
196 intervention manual and training materials; printing of adapted training manuals, staff recruitment, 
197 training and supervision. Supervision costs included time spent by master trainer, supervisors, transport 
198 costs for fieldwork supervision, and costs of all other resources used.  
199
200 To estimate the cost of intervention delivery, we evaluated unit cost per minute of health care providers’ 
201 time including the international master trainer/supervisor, local supervisors, lay health workers and 
202 physicians. The unit cost per minute was multiplied with the total estimated time spent by each health 
203 care provider to the participants to calculate the total cost of intervention delivery. We calculated the 
204 cost of intervention delivery with the international master trainer/supervisor and modelled the cost for 
205 a local supervisor as a potentially more sustainable way to support task-shifting in low resource settings. 
206 Costs of the intervention were calculated by multiplying the total contact time (number of minutes) a 
207 participant had in the intervention arm with a lay health worker by the per-minute cost of the lay health 
208 workers’ time and the costs spent on travelling by lay health workers (unit cost calculations are 
209 provided as web appendix). 
210
211 Calculation of these intervention costs as well as contacts with a range of formal health care providers 
212 was facilitated by the use of a simplified costing template for unit cost calculations reported in health 
213 economic evaluation of mental health services [23]. Unit cost templates accounted for the costs of 
214 salaries of staff employed in the provision of intervention delivery (including master trainer, 
215 supervisors, lay health workers and PHC staff), facility operating costs where the service was provided, 
216 overhead costs relating to the provision of service (personnel, finance etc.) and the capital costs of the 
217 facility where the intervention was provided (land, buildings etc.). Sources of data for these variables 
218 included public health system financial records and project’s financial records. All costs were cal-
219 culated in Pakistani rupees (PKR) and are reported in Pakistani Rupees and United States Dollars for 






220 the year 2016, when the study was implemented (1Exchange rate 1 USD= PKR 104). No adjustment 
221 was made for Purchasing Power Parity (PPP) since the focus of interest was on the actual resource costs 
222 incurred in the study country (rather than a comparison to other countries, whereby differences in the 
223 relative price of goods and services would need to be taken into account). 
224
225 Statistical Analysis 
226 The mean and standard deviation for the total cost was calculated using generalized linear regression 
227 model with Gamma distribution after adjustment for baseline total cost. The group difference and its 
228 95% CI was also calculated [24]. The Incremental Cost-effectiveness Ratio (ICER) was calculated as 
229 the additional costs of the intervention divided by the change in HADS-A, HADS- D, HADS Total, 
230 PHQ, and WHODAS related to the intervention. The confidence intervals for ICER was estimated by 
231 non-parametric bootstrapping. The bootstrap technique sampled with replacement from the original 
232 observed paired of costs and effects, maintaining the correlation structure between costs and benefits, 
233 to create a new dataset with 1000 observations. For each bootstrap resample, an estimate of differential 
234 total mean costs, expected mean effectiveness was calculated [25]. The 95% CIs for the differential 
235 estimates were derived from the calculated 2.5th and 97.5th percentiles. We plotted cost-effectiveness 
236 acceptability curves [26] to evaluate  the probability of PM+ intervention being cost-effective at 
237 increasing monetary values representing willingness-to-pay thresholds for PM+ intervention from 
238 policy makers’ perspective [27]. For the effectiveness data, we used linear mixed models to study 
239 treatment effects as indicated in our main trial report [12] which allowed the number of observations 
240 to vary at random between subjects and effectively handles missing data [28].the post hoc sensitivity 
241 analysis using multiple imputation was performed to assess the robustness of treatment effect to the 
242 missing values. 14% cost data was missing for medicines, complementary medicines, seeking retreats 
243 and religious help and for outpatient services at the end point. Summary stats for each specific cost 
244 were presented without imputation but the total cost were calculated assuming missing data as 0 in a 
245 conservative way [25]. 
246
247 Results 
1 Global Economic Data, Indicators, Charts, & Forecasts: CEIC
https://www.ceicdata.com/en






248 As reported in the clinical effectiveness evaluation [12], mean combined depression and anxiety 
249 symptom scores on HADS were significantly lower at 3-months post-intervention (AMD, −5.75; 95% 
250 CI, −7.21 to −4.29). Similarly, functional impairment significantly improved (AMD, −4.17; 95% CI, 
251 −5.84 to −2.51) on WHODAS-12 in the intervention arm compared to EUC arm. At baseline depression 
252 rate was 94.2% and 89.4% in intervention and EUC arms respectively. at the end of 3-months follow 
253 up period, the intervention arm had significantly lower rates of depression (26.9%) compared to EUC 




258 No significant difference in the cost of other health-care services accessed by study participants was 
259 observed between treatment and control groups, with the exception of religious help and retreats. The 
260 mental health condition of the majority of trial participants did not result in reduction in their or their 
261 family members or friends’ usual work/activities (Table 1).  Table 2 presents summary statistics and 
262 cost results from the mixed-model analysis.  
263
264 With an international master trainer/supervisor total cost of delivering PM+ intervention per participant 
265 was PKR 16,967 (US $ 163.14). Total intervention arm costs (PM+ costs plus cost of services accessed 
266 by intervention arm) was PKR17,473 (SD, 912) or US$ 168.  The cost of EUC (treatment as usual plus 
267 cost of services accessed by control arm participant) was PKR 848 (SD, 1734) or US $ 8.15 (See Table 
268 2).  
269 Substituting the cost of international master trainer/supervisor with national trainer would substantially 
270 decrease intervention costs. Total cost of delivering PM+ intervention, involving a national master 
271 trainer/supervisor, was estimated to be PKR 3,645 (US $ 35.04). This would be PKR 729 (US $ 7.00) 
272 per session. Total costs of delivering the intervention (with a national trainer/supervisor) plus EUC in 
273 the intervention arm would be PKR  4151 (SD, 912) or US$ 40.
274
275 Cost-effectiveness 






276 Incremental cost-effectiveness ratios (ICERs) indicate that the intervention was both more effective 
277 and costlier than EUC for all the health outcomes studied (Table 3). Analysis was conducted to evaluate 
278 the cost-effectiveness of PM+ intervention under two scenarios; 1) PM+ delivery by lay health workers 
279 supervised by international master trainer/supervisor (as observed in the trial) and 2) PM+ delivery by 
280 lay health workers supervised by local supervisor. The second scenario will be the case for scale-up of 
281 the intervention package in real world setting.  The additional costs associated with the intervention led 
282 to a relative improvement in outcomes, e.g. the mean cost per unit score improvement in anxiety and 
283 depression on HADS was PKR 2957 (95% CI: 2262, 4029) or US$ 28 with an international 
284 trainer/supervisor. This would be PKR 588 (95% CI: 434, 820) or US$ 6 with a national 
285 trainer/supervisor; with an international supervisor, each 1-point improvement on WHODAS costed 
286 PKR 4097 (95% CI: 2978, 6046) or US$ 40 and with a national supervisor it was estimated to be PKR 
287 815 (95% CI: 576, 1225) or US$ 8. We plotted 1,000 resampled estimates of costs and outcomes on a 
288 cost-effectiveness plane for the primary and secondary outcomes. The results show that all the 
289 resampled estimates fall in the upper-right quadrant, i.e. PM+ intervention is ‘more effective but 
290 costlier’ in all of the resampled estimates. 
291 The mean ICER to successfully treat a case of depression (PHQ-9 cut-off 10 or above) using an 
292 international supervisor was PKR 53,770 (95% CI: 39,394, 77,399) [US$ 517] versus a local supervisor 
293 PKR 10,705 (95% CI: 7731, 15,627) [US$ 102.93].  ICERs for other outcome measures are compared 
294 in Table 3. 
295 The cost-effectiveness acceptability curves of PM+ intervention on the outcomes of HADS (anxiety & 
296 depression) and WHODAS-12 with an international specialist supervisor are provided in Figures 1a 
297 and 2a. The intervention has more than 90% probability of being cost-effective as compared to EUC 
298 above a willingness-to-pay threshold of PKR 7000 (US$ 67) for a one-point improvement in depression 
299 and anxiety (HADS Total) (Figure 1a) and PKR 6000 (US$ 57) for a one-point improvement in 
300 functioning (WHODAS) using international supervisors (Figure 2a). These thresholds would be 
301 reduced by 80% using local supervisors (Figure 1b & 2b). 
302 Discussion 






303 Our results show that PM+ intervention is more effective and more costly than EUC in reducing 
304 symptoms of anxiety and depression. Although there is inevitable uncertainty around point estimates, 
305 our analysis has shown that even at very modest levels of willingness to pay for a one-point 
306 improvement in symptoms or functioning outcomes there is at least a 90% probability of this 
307 intervention being a cost-effective use of resources compared to enhanced usual care. We concluded 
308 that the value is ‘modest’ because that amount is equivalent to, for example, less than 10% of the 
309 minimum monthly wage in Pakistan in 2017 [29]. These findings are consistent with evidence from 
310 LMICs on the cost-effectiveness of task-shifting approach to deliver psychological interventions 
311 compared with EUC delivered by primary health care physicians, for the treatment of common mental 
312 disorders [30, 31]. With the current model of training and supervision from international master 
313 trainer/supervisor, the intervention was 5 times more costly for treating one person with depression, 
314 compared to modelled costs of training and supervision from local trainers. This emphasizes the need 
315 for building the capacity for local mental health workforce [32].
316 The resources, capacity and infrastructure for mental health services research including health 
317 economic evaluation alongside randomized controlled trials is limited in humanitarian settings of 
318 LMICs [33]. This is one of the very few studies to evaluate the cost-effectiveness of a psychological 
319 intervention in a humanitarian setting. There are only a few published studies on the cost-effectiveness 
320 of task-shifting interventions in global mental health. Araya et al (2006) evaluated the incremental cost-
321 effectiveness of a stepped-care multicomponent program for the treatment of depressed women in 
322 primary care in Chile. The stepped-care program was more effective and costlier than usual care (an 
323 extra US$ 0.75 per depression-free day) [34].  Buttorff et al (2012) conducted an economic evaluation 
324 of a task-shifting intervention for the treatment of depressive and anxiety disorders in primary-care 
325 settings in India. They concluded that the use of lay heath workers for treatment of CMDs in the public 
326 primary-care facilities was not only cost-effective but also cost-saving. The mean health system cost 
327 per case recovered at the end of follow-up was US$ 128 (95% CI: 105 to 157) in the intervention arm 
328 and US$ 149 (95% CI: 131 to 169) in the control arm [30]. Other similar studies of lay-health counsellor 
329 delivered psychological interventions from India [31] have replicated the findings of cost-effectiveness 
330 of task-shifting interventions for treating depression and alcohol problems in primary care settings.   
331 Sikandar et al., (2019) evaluated the cost-effectiveness of a peer-volunteer delivered CBT based 






332 intervention for post-natal depression versus EUC in community settings of rural Pakistan. The 
333 intervention was costlier as compared to EUC but was effective in improving the severity of post-natal 
334 depression (costs per unit improvement in PHQ-9 score of US $15·50 (9·59 to 21·61) for the whole 
335 study period. The intervention had a 98% probability of being cost-effective over a willingness-to-pay 
336 threshold of US$ 60 per unit of improvement on PHQ-9 score  compared to EUC [35]. Although it is 
337 difficult to compare the results of cost-effectiveness evaluations across studies due to differences in 
338 analytical approaches, treatment conditions and different outcome measures, the results of these studies 
339 demonstrate cost-effectiveness of brief psychological intervention using a task-shifting approach.  
340 During humanitarian crises, health systems tend to be overwhelmed, human resources are overstretched 
341 and access to specialists for referral and support is limited. It is therefore, important to determine how 
342 interventions with proven efficacy can be scaled-up in a cost effective way [36]. Our study and evidence 
343 from the literature supports the effectiveness of implementation strategies such as task-shifting and 
344 trans-diagnostic approaches to bridge the treatment gap for mental health problems in low resource 
345 settings. With the increased availability of evidence-based psychological intervention packages, further 
346 health economic evaluations are needed to inform the resource needs to scale-up evidence-based care 
347 for mental health. 
348 Limitations 
349 A limitation of the cost-effectiveness approach used in our study is that the results are limited to direct 
350 health care costs and health-related outcomes of PM+ intervention, and does not extend to the wider 
351 economic or social value of investing in mental health, which may be quite significant in a humanitarian 
352 context.  The future health economic evaluations in global mental health will benefit by integrating the 
353 opportunity and time cost of lay health workers and non-specialists. The added value that results from 
354 such task-sharing implementation strategies in terms of empowerment, opportunities and career growth 
355 for non-specialist health work force as well as increase in treatment coverage for priority mental health 
356 conditions will also need to be accounted for in future studies.  We did not make any adjustment for 
357 purchasing power parity since the focus of this study was on the actual resource costs incurred in the 
358 study country. However, for the purpose of international comparison, the PPP adjusted total 
359 intervention costs of PM+ were I$ 546 per participant. Estimated costs of delivering PM+ using a 
360 national master trainer in Pakistan would be I$ 114 per participant. Another limitation of our study is 






361 that we estimated costs per point reduction in symptoms of anxiety and depression and cost per case 
362 recovered from depression which limits the ability to compare results with other interventional studies 
363 on the basis of cost-utility measures (QALYs).  Future studies may use change in health outcomes that 
364 are easily interpretable and meaningful enough for policy makers to make decision and should also 
365 collect data on population-based health state preference scores that would enable the calculation of 
366 Quality Adjusted Life Years (QALYs). 
367 Conclusions
368 The literature on cost effectiveness of interventions for treating common mental disorders in LMICs, 
369 especially in humanitarian context is limited to only few studies. Present study provides the evidence 
370 on cost-effectiveness of a task-shifting intervention using a trans-diagnostic approach. We found that 
371 the intervention was effective but more costly for treating one person with depression when training 
372 and supervision to lay health workers was provided by an international master trainer. We conclude 
373 that PM+ may be a cost-effective intervention by using the training and supervision provided by the 
374 local health workers in primary health care settings. With the increased availability of evidence-based 
375 psychological intervention packages, further health economic evaluations are needed to inform the 










Table 1: *Health services utilization (including religious help and retreats, inpatient services and reduced 
usual work/activities due to health condition) across two arms at baseline and during past 3-months 
Baseline Endpoint











































professional TAU 76 
(24.5)





























































---Religious help and retreats
TAU 45 
(13.4)



















work/activities due to health 
condition (oneself/family 











member) TAU 1 (0.3) -- --- 1 
(0.3)
--- ---
 * Night stays in hospital- In case of inpatient services only
** Mean number of days of reduced usual work/activities due to health condition (oneself/family 
member)






Table 2:  Cost of health services (outpatient, inpatient care, drugs and complimentary medicines 
and religious retreats) by trial arm in PKR (1 USD = 104 PKR; 2016)
Descriptive statistics
n; mean* (SD)*
Intervention (N=172) EUC (N=174)Cost of Services Time point
N Mean  (SD) N Mean (SD)
Difference in LS 
mean (95%CI)
p-value
Out-patient care Pre-Treatment 106 2641 (14946) 95 727 (1161)
Follow-Up 73 485 (651) 72 667 (1033)  -182 (-465,101) 0.206
Change since 
baseline 
49 743(2751) 41 305(984) 437(-462,1281) 0.336
In-patient care Pre-Treatment 170 135 (929) 172 273 (1545)
Follow-Up 142 49 (344) 155 171 (1056) -122 (-304,61) 0.191
Change since 
baseline
140 114(866) 153 108(1953) 6(-337,349) 0.971
Drugs/medications Pre-Treatment 158 736 (1364) 159 725 (1232)
Follow-Up 132 277 (650) 149 228 (461) 50 (-82,181) 0.458
Change since 
baseline
124 378(1314) 136 496(1341) -118(-442,207) 0.477
Complimentary 
medicines 
Pre-Treatment 168 124 (624) 167 110 (945)
Follow-Up 139 10 (88.14) 156 3 (40) 7 (-9,22) 0.393
Change since 
baseline
136 55(456) 150 115(998) -60(-244,123) 0.518
Religious Retreats Pre-Treatment 167 390 (2208) 165 674 (3773)
Follow-Up 136 4 (43) 154 131 (655) -127 (-238,-17) 0.024
Change since 
baseline
131 432(2451) 145 626(4080) -193(-983,596) 0.638
Total cost of all 
services 
Pre-Treatment 172 3145 (14302) 174 2445 (6053)
Follow-Up 145  601 (694) 159 848 (1734) -247 (-568,73) 0.130
Change since 
baseline
145 2746 (15491) 159 1714 (6632) 1032(-1709,3774) 0.444





172 17473 (912) 159 848 (1734) 16625 
(16329,16922)
<.0001




172 4151 (912) 159 848 (1734) 3303 (3007,3600) <.0001
Table 2 shows costs of other services accessed by the participants. The data was collected using CSRI at baseline 
and 3 months’ post-intervention follow-up assessment. 
2 Intervention costs plus cost of services. The cost of intervention with international supervisor is PKR 16,967
3 Intervention costs plus cost of services. The cost of intervention with local supervisor is PKR 3,645






Table 3:  Incremental Cost Effectiveness Ratios (ICERs) for PM+ intervention in PKR (1 USD = 
104 PKR; 2016)
International specialist  supervisor Local specialist supervisor 
Endpoint Mean ICER 95% CI Mean ICER 95% CI
HADS Anxiety 6172.99 [4575.49,8787.73] 1228.91 [882.86,1796.12]
HADS Depression 5704.27 [4384.51, 7651.85] 1135.81 [849.23,1561.68]
HADS Total 2957.45 [2261.64, 4029.00] 588.82 [434.01,820.27]
WHO DAS 4096.51 [2978.13, 6045.66] 815.89 [575.80,1225.10]
Depression caseness 53769.91 [39393.57, 77398.62] 10705.35 [7730.95,15627]
Note: (1) The cost was estimated after adjusting several baseline variables (baseline total cost, age, gender, occupation, marital 
status). (2) We used non-parametric bootstrapping to estimate confidence intervals with1000 resamples.
Abbreviations.; HADS = Hospital Anxiety and Depression Scales (subscale score range: 0-21; higher scores indicate elevated 
anxiety or depression, respectively); WHODAS = WHO Disability Assessment Schedule (total score range: 0-48; higher scores 
indicate more severe impairment); Depression caseness defined as (PHQ-9 cut-off 10 or above), PHQ = Patient Health 
Questionnaire 






Figure 1a: Cost-effectiveness acceptability curve for PM+ with international supervisor (in PKR) (1 USD 
= 104 PKR; 2016)






Figure 1b: Cost-effectiveness acceptability curve for PM+ - with local trainer (in PKR) (1 USD = 104 
PKR; 2016)






Figure 2a: Cost-effectiveness acceptability curve for PM+ with international supervisor (in PKR) 
(1 USD = 104 PKR; 2016)






Figure 2b: Cost-effectiveness acceptability curve for PM+ with local supervisor (in PKR) (1 USD 
= 104 PKR; 2016)
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